pharmaphorum

NOVEMBER 22, 2021

The 2nd annual Mitochondria-Targeted Drug Development Summit returns as the only industry-led meeting focused on overcoming the challenge of treating unmet medical needs caused by mitochondrial dysfunction. Download the full event guide for the speaker faculty and session details.

Drug Development 98

Drug Development 98

STAT

JANUARY 9, 2024

In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The Readout. To stay on top of the latest scoops and live reporting from the San Francisco conference,  join our newsletter list.

Drug Pricing 215

Drug Pricing Drug Development 215

pharmaphorum

JUNE 15, 2022

The 2nd NSCLC Drug Development Summit returns for its second year to unite biopharma and academic leaders during an exciting era of personalized medicine. Improve your drug development rationale across all lines of NSCLC and address challenges when moving therapies forward. Progress sequencing and combination approaches.

Drug Development 105

Drug Development Immunity Immunization 105

STAT

APRIL 1, 2025

If you’ll also be there, come to our STAT event on Sunday night! I’ll be talking with researchers about the potential of using GLP-1 drugs for neurological conditions, and my Readout co-writer Meghana will be chatting with BMS’ head of development about the launch of their new schizophrenia drug Cobenfy.

Drug Pricing 172

Drug Pricing Drug Development 172

STAT

MAY 30, 2024

Say hi if you’re attending our  STAT event  on Friday night!   Sign up  to get our biotech newsletter in your inbox. Good morning. A big welcome to everyone coming to Chicago for ASCO this weekend. Read the rest…

Drug Pricing 249

Drug Pricing Drug Development 249

pharmaphorum

JANUARY 25, 2021

The Mitochondria-Targeted Drug Development Digital Summit (April 27-29) is the only industry-led meeting focused on end-to-end mitochondria-targeting. Join your peers this spring to collaborate and share learnings, whilst evaluating your clinical development landscape.

Drug Development 98

Drug Development 98

STAT

OCTOBER 2, 2024

Today, we look at the biggest biotech events to watch this quarter.   Sign up for The Readout  and receive STAT’s award-winning biotech news delivered straight to your inbox.    Good morning. And as my editor had to remind me (since I’m still in denial), we are indeed in the fourth quarter now.

Drug Pricing 251

Drug Pricing Drug Development 251

European Pharmaceutical Review

SEPTEMBER 22, 2022

Rare disease drug development poses unique challenges that can be overcome by using real-world evidence (RWE). Two different methodologies are used in the application of HC information in clinical development. RWE from rare diseases is available from a wide variety of sources for use as an HC in rare disease drug development.

Drug Development 122

Drug Development Pharmaceutical Companies Pharmaceutical Companies Documentation 122

STAT

JUNE 7, 2024

Well, this wraps up one of the most eventful weeks of the biotech year — ASCO, followed by BIO. Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Anyone else as zonked as I am?

Drug Pricing 243

Drug Pricing Drug Development 243

STAT

MAY 22, 2024

Using real-world data to monitor drug safety and effectiveness adds an important capability to identify ways to improve patient and clinician experiences with a drug, based on side effects, adverse events, prescribing patterns, and patients’ subsequent care needs following their use of a drug.

Pharmaceutical Companies 268

Pharmaceutical Companies Pharmaceutical Companies Drug Development 268

Express Pharma

DECEMBER 30, 2024

They offer various programs, from undergraduate degrees in pharmaceutical sciences to specialised graduate courses focusing on drug development, regulatory affairs, and market access. Moreover, hands-on experience through internships and networking events is invaluable for students.

Pharmaceutical Companies 106

Pharmaceutical Companies Pharmaceutical Companies Drug Development 106

European Pharmaceutical Review

JULY 21, 2023

European Medicines Agency (EMA) has published a draft reflection paper on using artificial intelligence (AI) to support the safe and effective development, regulation and use of medicines. How can AI be best harnessed for pharmacovigilance data?

Drug Development 98

Drug Development Documentation 98

Drug Patent Watch

DECEMBER 10, 2024

They can help ensure that these submissions are complete, accurate, and timely, which is critical for advancing drug development programs. They can assist with analytical method development and validation, stability testing, and characterization of drug substances and products.

Documentation 98

Documentation Drug Development Pharmaceutical Manufacturing Pharmaceutical Companies 98

STAT

JANUARY 30, 2024

The company reported that its small molecule drug, VX-548, outperformed placebo in a pair of pain relief trials that recruited patients who had gotten an abdominoplasty (tummy tuck) or bunion surgery. But there was a catch: VX-548 didn’t outperform a combination of acetaminophen and the opioid hydrocodone, a key secondary endpoint.

Drug Development 314

Drug Development 314

pharmaphorum

JULY 19, 2022

Regulators are increasingly asking drug developers to include the patient voice in submissions, but the best way to go about this is less clear-cut. In the United States, learning how to navigate forums such as the FDA’s listening sessions and patient-focused drug development (PFDD) meetings could be the key to “truly moving the dial”.

Drug Development 105

Drug Development Communication 105

STAT

NOVEMBER 8, 2023

Of course,” Hudson said at a Financial Times event in London. “Would I have liked the stock market reaction to be more generous? “But this is a long-term game, and if you’re trying to deliver long-term value, you try not to make too many short-term decisions.”

Drug Development 303

Drug Development 303

STAT

DECEMBER 5, 2023

Damian here with a special thanks to everyone who joined us for STAT’s live event in New York City last night.   Sign up  to get our biotech newsletter in your inbox. Good morning, everyone.

Drug Pricing 238

Drug Pricing Drug Development 238

STAT

OCTOBER 9, 2023

LONDON — At an event here last week, the German pharmaceutical firm Boehringer Ingelheim outlined the projects in its pipeline.     There was obesity and liver disease, and computational biology and oncology. Then respiratory and inflammatory diseases. And don’t forget mental illness and retinal health.

Biosimilars 243

Biosimilars Drug Development 243

pharmaphorum

FEBRUARY 6, 2025

The 7th Neuroimmunology Drug Development Summit, organised by Hanson Wade, is a premier event bringing together experts in the field to discuss the latest advancements and challenges in neuroimmunology drug development. Find out more about this must-attend event.

Drug Development 52

Drug Development 52

STAT

DECEMBER 6, 2022

NEW YORK — A consensus may be emerging about how to prescribe the new Alzheimer’s drug lecanemab , according to remarks made by both a critic of other Alzheimer’s medicines and the CEO of the company that developed it.

Drug Pricing 246

Drug Pricing Drug Development 246

STAT

SEPTEMBER 20, 2023

In June, Viatris filed a citizen petition with the FDA, saying that the available evidence left doubts about how neffy would actually perform in a real-life anaphylactic event compared to auto-injectable epinephrine. (A generic version is also available, made by Teva). Continue to STAT+ to read the full story…

Drug Development 280

Drug Development 280

STAT

SEPTEMBER 26, 2023

Researchers reported that the treatment was also generally safe, with fewer adverse events among those on olezarsen than among the placebo group. Continue to STAT+ to read the full story…

Drug Development 265

Drug Development 265

Pharmaceutical Technology

SEPTEMBER 12, 2022

Baudry is also the chief scientific advisor at NeurAegis, a preclinical-stage company developing a concussion drug. There can be serious downstream events after a concussion, like dementia , particularly with multiple concussions, explains Oxeia CEO Michael Wyand. Development bogged down by complexity.

Drug Development 94

Drug Development Compounding 94

STAT

OCTOBER 2, 2023

Researchers also reported that the most common adverse events, diarrhea and headache, were mild. The study’s authors found that, when patients were on Chenodal, their level of bile alcohols was more than 20-fold lower than when they were on placebo, which was both the desired result and statistically significant.

Drug Development 252

Drug Development 252

Pharmaceutical Technology

FEBRUARY 23, 2023

Many compounds present sub-optimal pharmacokinetic (PK) data (either predicted from in-vitro and pre-clinical data or measured in the clinic), such as poor exposure (leading to high doses), large variability, short half-life requiring more than once-a-day dosing, or C max -related adverse events (AEs). S54 – S61 (2001).

Drug Development 98

Drug Development Compounding Dosage Packaging 98

pharmaphorum

NOVEMBER 1, 2024

The 8th Antigen-Specific Immune Tolerance Drug Development Summit is an event organised by Hanson Wade. Discover the latest developments and networking opportunities at this leading industry conference.

Immunity 52

Immunity Immunization Drug Development 52

STAT

JUNE 9, 2023

The results, which also showed no serious adverse events tied to the therapy, Edit-301, were announced coinciding with the European Hematology Association’s annual meeting in Frankfurt. Continue to STAT+ to read the full story…

Drug Development 236

Drug Development 236

PharmExec

APRIL 14, 2025

Odylia Therapeutics event brings together leaders across biotech, pharma, venture capital, patient advocacy, and research sectors to address the financial and structural barriers that impede rare disease drug development.

Drug Development 52

Drug Development 52

STAT

FEBRUARY 16, 2024

the curious story of the latest FDA drug approval, and a twist on the year’s biggest biotech event. Damian here with a look at pharma’s struggle to make inroads in D.C., Read the rest…

Drug Pricing 189

Drug Pricing Drug Development 189

pharmaphorum

OCTOBER 13, 2021

The Gastrointestinal Cancer Drug Development Summit is the only biopharma-led conference dedicated to identifying and progressing therapeutic opportunities in targeted and immunotherapies, ADCs, and precision oncology to address the large unmet clinical need in GI cancers. Explore the full event guide here: [link]. **A

Drug Development 52

Drug Development Immunity Immunization 52

pharmaphorum

MARCH 21, 2022

Neuroscience is arguably the next great frontier in medicine and 2022 dawned with a wave of exhilarating progress for the neurodegenerative drug development community. Download the full event guide for the speaker faculty and session details. Download the full event guide for the speaker faculty and session details.

Drug Development 52

Drug Development 52

Viseven

JULY 25, 2024

In the second quarter of 2024, the Viseven team embarked on a global journey, traversing continents to attend and participate in the world’s most prominent pharmaceutical events. Reuters Pharma EU 2024 April was a whirlwind for us, kicking off with the Reuters event in Barcelona where we went all out.

Communication 52

Communication Drug Development 52

STAT

JUNE 5, 2023

It’s true that the FDA has no obligation to follow what the advisory committee recommends, but the votes help, Pazdur said at STAT@ASCO, STAT’s event at the American Society of Clinical Oncology annual meeting. On Sunday, Richard Pazdur, director of the FDA’s Oncology Center of Excellence, took issue with his boss.

Drug Development 236

Drug Development 236

pharmaphorum

APRIL 20, 2021

The Non-Small Cell Lung Cancer (NSCLC) Drug Development Summit is the definitive industry-led forum for drug development in the largest solid tumor indication. View the event guide now for the full agenda details and expert speaker faculty. View the event guide now for more details!

Drug Development 52

Drug Development Medical Schools Immunity Immunization 52

pharmaphorum

OCTOBER 7, 2022

As we continue enriching the design and development of molecular glues, network with 80+ leading Chemists, Biologists, Bioinformaticians, Structural Scientists & Computational Chemists at the world’s first-of-a-kind meeting to successfully accelerate the first wave of molecular glues into the clinic. View the full event guide Here.

Drug Development 52

Drug Development 52

pharmaphorum

OCTOBER 14, 2022

As the only industry-led forum providing biopharma with the insights necessary to make strategic and scientific decisions on their fibrosis pipeline, the 6th Antifibrotic Drug Development Summit returns to host the unmissable conversations transforming antifibrotic drug development research. View the official agenda here.

Drug Development 52

Drug Development 52

pharmaphorum

OCTOBER 27, 2021

Download the full event guide for the speaker faculty and session details. areas for 2022 include: Understanding the Pre- Clinical & Clinical Developments of Microbiome-based Therapeutics – INCLUDING a Range of Disease-Specific Case Studies. With over 50 speakers each sharing brand new sessions, the main focus?areas

Drug Development 52

Drug Development 52